2025-06-14-Jefferies-布伦泰格公司（BNR）_下调至表现不佳_销量和利润率压力持续_展望系列专题_13页_625kb

Brenntag SE Equity Research Summary

• Downgrade Overview: Jefferies downgrades Brenntag SE from Hold to Underperform due to persistent operational underperformance and revised lower financial estimates. Price target reduced from €61.06 to €53/share.

• Key Reasons for Downgrade:

  • Global compression of chemical production costs impedes cross-regional sourcing advantages.
  • Weaker customer demand and declining volumes contribute to earnings risks.
  • Widening operational gap relative to peers in areas like organic growth, EBITA margins, and FCF conversion.

• Financial Projections:

  • EBITA estimated at €1,395mn for 2025, 7% below consensus, due to increased variable costs and reduced savings.
  • Average mid-term EBITA margins at 8.6%, still lagging peers by a 40-bps gap.
  • Rev 2024-2027: €16,237mn to €18,326mn (via organic growth averaging 3%).

• Operational Challenges:

  • Organic sales growth volatile and underperforming peers by 190-420 bps marginally.
  • Specialties segment faces weak demand and lower gross profit margins.
  • Cost overhang from CapEx and restructuring may persist due to Didex program delays.

• Valuation Analysis:

  • Price target reduced to €53/share (average of SOTP €52 and DCF €55).
  • Trades at 31% EV/EBITDA discount vs 34% historical average, sustained due to operational gaps.
  • Peers (IMCD, Azelis) have higher valuations but face similar risks.

• Outlook and Catalysts:

  • Catalyzed events: 2Q 2025 earnings (forecast €262mn EBITA vs €282mn consensus).
  • Risks: End-market demand slowdown, regional chemical price differentials, and execution uncertainties under new leadership.

• Strategic Focus:

  • New CEO/CFO to address cost management and portfolio diversification; separation may yield limited value swiftly.
  • Sustainability targets by 2030 (carbon neutrality) may pose additional costs.

• Additional Notes:

  • Charts and exhibits show widening performance gaps and correlation with declining chemical prices.
  • Analyst certifications confirm independence, but conflicts of interest noted due to business ties. This highlights Brenntag's status as a low-quality business with persistent structural weaknesses.